<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03092830</url>
  </required_header>
  <id_info>
    <org_study_id>0515-15-RMC</org_study_id>
    <nct_id>NCT03092830</nct_id>
  </id_info>
  <brief_title>Molecular Characterization of Cutaneous Tumors</brief_title>
  <official_title>Molecular Characterization of Cutaneous Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rabin Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rabin Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective is to find genes which are responsible for the appearance of skin tumors (sCC,
      BCC) and it will be the basis for prediction of the disease and response to the treatment
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, 1-arm, 500 participates above 18 age with skin tumor affliction sCC and BCC
      type.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 7, 2017</start_date>
  <completion_date type="Anticipated">August 7, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 7, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Molecular Characterization of cutaneous tumors</measure>
    <time_frame>5 years</time_frame>
    <description>samples from subjects</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Squamous Cell Carcinoma</condition>
  <condition>Basal Cell Carcinoma</condition>
  <arm_group>
    <arm_group_label>1-arm, 500 participates</arm_group_label>
    <description>Molecular testing of DNA/RNA from skin tumors, SCC/BCC</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Molecular testing of DNA/RNA from skin tumors, SCC/BCC</intervention_name>
    <description>Molecular testing of DNA/RNA from skin tumors, SCC/BCC</description>
    <arm_group_label>1-arm, 500 participates</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA or RNA which will be produced from skin biopsy specimens of SCC,BCC
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        above 18 years old with Scc and BCC skin tumors not pregnant women and no children or any
        person without judgment ability
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient that have sCC and BCC tumors

          -  above 18 years old

        Exclusion Criteria:

          -  below 18 years old

          -  pregnant women

          -  children or person without judgment ability
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>DR Dean Ad EL, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rabin Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>DR Dean Ad EL, MD</last_name>
    <phone>+972-3-9376366</phone>
    <email>deana@clalit.org.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>DR Asaf Olshinka, MD</last_name>
    <phone>+972-3-9376366</phone>
  </overall_contact_backup>
  <reference>
    <citation>Winder M, Vir√≥s A. Mechanisms of Drug Resistance in Melanoma. Handb Exp Pharmacol. 2017 Mar 9. doi: 10.1007/164_2017_17. [Epub ahead of print]</citation>
    <PMID>28275910</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2017</study_first_submitted>
  <study_first_submitted_qc>March 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 28, 2017</study_first_posted>
  <last_update_submitted>March 27, 2017</last_update_submitted>
  <last_update_submitted_qc>March 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>SCC</keyword>
  <keyword>BCC</keyword>
  <keyword>DNA</keyword>
  <keyword>RNA</keyword>
  <keyword>HEDGE HOG</keyword>
  <keyword>epidermal growth factor receptor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
    <mesh_term>Carcinoma, Basal Cell</mesh_term>
    <mesh_term>Skin Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

